Unprotected left main intervention: patient selection, operator technique, and clinical outcomes

Area of Science:

• Interventional Cardiology
• Cardiovascular Surgery
• Medical Device Technology

Background:

• Early balloon angioplasty for unprotected left main coronary artery (UPLM) had high mortality due to complications.
• Bare-metal stents reduced acute issues but had high restenosis and revascularization rates.
• Drug-eluting stents (DES) were developed to significantly decrease restenosis in UPLM interventions.

Purpose of the Study:

• To evaluate the safety and efficacy of DES for UPLM interventions.
• To compare outcomes of DES in UPLM with historical coronary artery bypass graft (CABG) data.
• To assess the impact of lesion location (ostial, midshaft, distal bifurcation) on UPLM stenting outcomes.

Main Methods:

• Review of published registries on DES implantation for UPLM.
• Comparison of procedural/in-hospital risks with CABG.
• Analysis of early and midterm outcomes, including mortality and revascularization rates.

Main Results:

• Procedural and in-hospital risks for DES in UPLM appear acceptable and comparable to CABG.
• Ostial and midshaft UPLM lesions show promising early/midterm outcomes with DES.
• Distal UPLM bifurcation lesions are more challenging, with higher late revascularization rates. No excess mortality observed compared to CABG historical data.

Conclusions:

• DES implantation for UPLM is feasible with acceptable procedural risks, potentially offering similar outcomes to CABG for specific lesion types.
• Long-term outcomes, especially for distal UPLM bifurcations, require further investigation through randomized trials.
• While current follow-up is limited, early data suggest DES is a viable option for select UPLM patients.